These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 4389699)

  • 1. Monoamine oxidase activity of the cat nictitating membrane and superior cervical ganglion under various experimental conditions.
    Cervoni P
    Biochem Pharmacol; 1969 Jun; 18(6):1427-33. PubMed ID: 4389699
    [No Abstract]   [Full Text] [Related]  

  • 2. MAO-A and MAO-B in the superior cervical ganglion and in the nictitating membrane of the cat.
    Filinger EJ; Stefano FJ
    Gen Pharmacol; 1981; 12(6):481-4. PubMed ID: 7308736
    [No Abstract]   [Full Text] [Related]  

  • 3. Demonstration by the histochemical fluorescence method of the prolonged disappearance of catecholamines from the denervated nictitating membrane of the cat.
    Weiner N; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):284-9. PubMed ID: 6039820
    [No Abstract]   [Full Text] [Related]  

  • 4. The influence of intraneuronal monoamine oxidase on neuronal net uptake of noradrenaline and on sensitivity to noradrenaline.
    Trendelenburg U; Draskóczy PR; Graefe KH
    Adv Biochem Psychopharmacol; 1972; 5():371-7. PubMed ID: 5054208
    [No Abstract]   [Full Text] [Related]  

  • 5. The mechanism of norepinephrine depletion by reserpine, metaraminol and related agents. The role of monoamine oxidase.
    Shore PA
    Pharmacol Rev; 1966 Mar; 18(1):561-8. PubMed ID: 4379288
    [No Abstract]   [Full Text] [Related]  

  • 6. Monoamine oxidase and catechol-O-methyl transferase activities in cat nictitating membrane and rat and guinea-pig vas deferens after sympathectomy.
    Iversen LL; Jarrott B; Langer SZ
    Br J Pharmacol; 1968 Nov; 34(3):693P-694P. PubMed ID: 5726819
    [No Abstract]   [Full Text] [Related]  

  • 7. Histochemical and fine structural aspects of the onset of denervation supersensitivity in the nictitating membrane of the spinal cat.
    Van Orden LS; Bensch KG; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1967 Aug; 157(2):274-83. PubMed ID: 6039819
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in monoamine oxidase and catechol-0-methyl transferase activities after denervation of the nictitating membrane of the cat.
    Jarrott B; Langer SZ
    J Physiol; 1971 Jan; 212(2):549-59. PubMed ID: 5548022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of beta-TM 10 on the pharmacological, biochemical and morphological changes induced by denervation of the nictitating membrane in the cat.
    Pluchino S; Van Orden LS; Draskóczy PR; Langer SZ; Trendelenburg U
    J Pharmacol Exp Ther; 1970 Mar; 172(1):77-90. PubMed ID: 5416947
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction between some cheeses and monoamine oxydase inhibitors.
    Kayaalp SO; Kaymakçalan S; Ozer A
    Arzneimittelforschung; 1968 Sep; 18(9):1195-8. PubMed ID: 5756049
    [No Abstract]   [Full Text] [Related]  

  • 11. Cholinergic transmission in the hypoglossal reinnervated nictitating membrane of the cat: an enzymatic, histochemical and physiological study.
    Koslow SH; Giacobini E; Kerpel-Fronius S; Olson L
    J Pharmacol Exp Ther; 1972 Mar; 180(3):664-71. PubMed ID: 4335112
    [No Abstract]   [Full Text] [Related]  

  • 12. Auto-potentiation and potentiation by inhibition of monoamine oxidase of the sympathomimetic action of phenelzine and pheniprazine.
    Clineschmidt V; Horita A
    Br J Pharmacol Chemother; 1967 May; 30(1):67-77. PubMed ID: 4382676
    [No Abstract]   [Full Text] [Related]  

  • 13. Application of steady-state kinetics to the study of catecholamine turnover after monoamine oxidase inhibition or reserpine administration.
    Neff NH; Costa E
    J Pharmacol Exp Ther; 1968 Mar; 160(1):40-7. PubMed ID: 5639109
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of monoamine oxidase and inhibition of aldehyde dehydrogenase by reserpine.
    Youdim MB; Sandler M
    Eur J Pharmacol; 1968 Aug; 4(1):105-7. PubMed ID: 5680364
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the decentralized nictitating membrane of the cat. II. Uptake and retention of norepinephrine and epinephrine.
    Cervoni P; Reit E; McCullough J
    J Pharmacol Exp Ther; 1970 Dec; 175(3):649-63. PubMed ID: 5489920
    [No Abstract]   [Full Text] [Related]  

  • 16. Catechol-O-methyltransferase in autonomic and sensory ganglia of the cat.
    Giacobini E; Kerpel-Fronius S
    Acta Physiol Scand; 1969 Apr; 75(4):523-9. PubMed ID: 5358872
    [No Abstract]   [Full Text] [Related]  

  • 17. Intraneuronal and extraneuronal accumulation of sympathomimetic amines in the isolated nictitating membrane of the cat.
    Draskóczy PR; Trendelenburg U
    J Pharmacol Exp Ther; 1970 Aug; 174(2):290-306. PubMed ID: 5451365
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of methylguanidine on norepinephrine metabolism in isolated, perfused spleen and heart.
    Cubeddu L; Mosimann W; Weiner N
    J Pharmacol Exp Ther; 1974 Jan; 188(1):93-106. PubMed ID: 4809281
    [No Abstract]   [Full Text] [Related]  

  • 19. [Some data on the pathways of interaction of corticosteroids and catecholamines].
    Ruchkina AS
    Ukr Biokhim Zh; 1967; 39(1):96-101. PubMed ID: 5603052
    [No Abstract]   [Full Text] [Related]  

  • 20. SYMPATHOMIMETIC ACTIONS OF MONOAMINE OXIDASE INHIBITORS IN THE ISOLATING NICITATING MEMBRANE OF THE CAT.
    TSAI TH; FLEMING WW
    Biochem Pharmacol; 1965 Mar; 14():369-71. PubMed ID: 14314337
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.